Track topics on Twitter Track topics that are important to you
SHANGHAI, Sept. 23, 2016 /PRNewswire/ -- Sundia MediTech Company, Ltd. ("Sundia") today announced that it has been selected as a winner of Red Herring's 2016 Top 100 Asia award. Sundia, a leading pre-clinical contract research organization ("CRO"), was recognized for its role as an important, long-term partner to global pharmaceutical and biotechnology companies throughout the drug discovery and development process. Through breakthrough discoveries and integrated solutions, Sundia has helped its partners accelerate innovation.
"We are delighted to be selected again by Red Herring as one of Asia's Top 100 companies." said Dr. Jim Li, Chief Executive Officer of Sundia. "This award is a testament to our employees' relentless efforts and contributions in providing our customers with unparalleled service and advice. We commit ourselves to delivering the highest quality service that complies with world-class standards. Moreover, each and every employee adheres to our core values of integrity, quality and innovation. This is why our customers continue to select us as their partner of choice."
"Selecting the top achievers from Asia in 2016 was extremely challenging," said Alex Vieux, publisher and chief executive officer of Red Herring. "The variety, depth, disruption and traction we saw from the early stage companies to those with significant scale made it one of the toughest vintages to judge. Sundia continues to show great promise and should be proud of its accomplishment under such strong competition."
Red Herring Top 100 Asia enlists outstanding entrepreneurs and promising companies. It selects the award winners from approximately 1,200 privately financed companies each year in Asia. Since 1996, Red Herring has kept tabs on these up-and-comers. Red Herring editors were among the first to recognize that companies such as Facebook, Twitter, Google, Yahoo, Skype, YouTube, Palo Alto Networks and eBay would change the way we live and work.
Founded in 2004, Sundia MediTech Company Ltd. is a leading China-based CRO. Capitalizing on its broad service offerings, experienced scientists and advanced research facilities and equipment, Sundia helps its customers discover and develop novel drug candidates efficiently. Sundia currently serves over 160 customers globally, including a vast majority of the top 20 pharmaceutical and biotechnology companies around the world, fast-growing biotechnology and specialty pharmaceutical companies as well as renowned academic and research institutions.
For more information, please visit: www.sundia.com
About Red Herring
Red Herring is a global media company uniting the world's best high technology innovators, venture investors and business decision makers in a variety of forums: a leading innovation magazine; an online daily technology news service; technology newsletters, and major events for technology leaders around the globe. Red Herring's lists of private companies are an important part of the magazine's tradition of identifying new and innovative technology companies and entrepreneurs.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sundia-selected-as-a-red-herring-top-100-asia-company-300333200.html
SOURCE Sundia MediTech Company Ltd.NEXT ARTICLE
Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...